| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 0 | 0 | 97.253 |
| Total Income - EUR | - | - | - | - | - | - | - | 0 | 0 | 100.045 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 672 | 8.395 | 86.810 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -672 | -8.395 | 13.235 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -672 | -8.395 | 11.627 |
| Employees | - | - | - | - | - | - | - | 0 | 2 | 3 |
Check the financial reports for the company - Ginkgomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 0 | 61.903 | 54.481 |
| Current Assets | - | - | - | - | - | - | - | 16 | 5.367 | 19.292 |
| Inventories | - | - | - | - | - | - | - | 0 | 400 | 0 |
| Receivables | - | - | - | - | - | - | - | 0 | 0 | 9.924 |
| Cash | - | - | - | - | - | - | - | 16 | 4.967 | 9.369 |
| Shareholders Funds | - | - | - | - | - | - | - | -631 | -9.025 | 2.653 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 647 | 79.654 | 35.383 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 39.245 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ginkgomed S.r.l.